CASE DISCUSSION

Latest Surgical Approaches to Oral Cancer

Presented from India by Dr. Abhimanyu kadapathri

Likes

169845

Views

6,794

5,095

Bookmarks

Case Description

Recent advancements in surgical approaches to oral cancer have emphasized precision and minimally invasive techniques. Robotic-assisted surgery and transoral laser microsurgery allow for enhanced accuracy, reducing damage to surrounding tissues. Surgeons also increasingly use image-guided...

Case Summary

The speaker, who has a background in infectious diseases and cancer research, discusses CAR T-cell therapy as a rapidly evolving field. He mentions his involvement with companies like Therosys (now Onomics) and Epistem Genomics, highlighting their research in CAR T-cells. He clarifies his role as having taken an exit from the company but not a financial one, emphasizing the current struggles faced by startups, especially big ones like biocon. The company is currently looking for somebody to buy their intellectual property and as a temporary measure has merged with one of their another company Epistem Genomics.

Speaker Profile

Dr. Abhimanyu kadapathri

Consultant Head and Neck Surgical Oncology , Paras Yash Kothari Hospital, Kanpur

Dr. Abhimanyu Kadapathri is a highly skilled Head & Neck Surgical Oncologist and ENT Consultant with extensive training and clinical experience. His academic journey includes an MBBS from Karnataka Lingayat Educational Society, an MS in ENT from Sri Devaraj Urs Academy, and advanced credentials from the Royal College of Surgeons of England, with a specialized fellowship in Head and Neck Oncosurgery. With notable experience in high-volume cancer centers like HCG Cancer Center, Medanta Hospital, and Narayana Health, Dr. Kadapathri has performed over 1,000 major cancer surgeries and is proficient in microvascular reconstruction, the revolutionary Jaw-In-A-Day (JIAD) procedure, and voice rehabilitation. He has authored more than 20 publications, received multiple awards, and is actively involved in healthcare AI initiatives and anti-tobacco programs. Currently, he is also pursuing an MBA from Liverpool Business School.

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.